Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

Ruyi Xue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5710-0091. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC. Last author DOI 10.1186/s10020-021-00347-7↗
  2. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo. Co-author DOI 10.1007/s10620-018-5253-7↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hanxing Tong · 1 shared paper, 2021 · strength 0.12
  2. Dayong Jin · 1 shared paper, 2021 · strength 0.12
  3. Yong Zhang · 1 shared paper, 2021 · strength 0.12
  4. Jinglei Li · 1 shared paper, 2021 · strength 0.12
  5. Xinyu Qin · 1 shared paper, 2021 · strength 0.12
  6. Yi Zhou · 1 shared paper, 2018 · strength 0.11
  7. Shuncai Zhang · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.